Search results for: Fabiano Palmieri

Items from 1 to 6 out of 6 results

article

Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non‐inferiority, open‐label, clinical study (SPRITE study)

Giuseppe Morgia, Giuseppe Vespasiani, Rosaria M. Pareo, Salvatore Voce, more

Objective To compare in a randomised, open‐label, non‐inferiority clinical study, the efficacy and tolerability of Serenoa repens (SeR) + selenium (Se) + lycopene (Ly) (SeR‐Se‐Ly) therapy vs tadalafil 5 mg in men with lower urinary tract symptoms (LUTS). Patients and methods From May 2015 to January 2017, 427 patients were enrolled in 21 different centres (International Standard Randomised Controlled...

article

Standard vs. anatomical 180-W GreenLight laser photoselective vaporization of the prostate: a propensity score analysis

Luca Cindolo, Cosimo De Nunzio, Francesco Greco, Paolo Destefanis, more

World Journal of Urology > 2018 > 36 > 1 > 91-97

Purpose To compare the efficacy, safety, Patient Global Impression of Improvement (PGI-I), and complications rates after 180-W GreenLight laser (180-W GL laser) standard and anatomical photoselective vaporization (sPVP and aPVP). Methods Within a multi-institutional database, we identified patients who underwent sPVP or aPVP to relief BPH symptoms. IPSS, Q_max, and prostate-specific antigen (PSA)...

article

Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial

Giuseppe Morgia, Salvatore Voce, Fabiano Palmieri, Marcello Gentile, more

Phytomedicine > 2017 > 34 > C > 1-5

Many potential chemopreventive agents have been used in PCa prevention, including selenium (Se) and lycopene (Ly). However, their role has been matter of debate over the years, due to potential of promotion of PCa.In this study we aimed at evaluating the incidence risk of prostate cancer (PCa) in a cohort of patients treated with Se and Ly.The Procomb trial design has been previously published (ISRCTN78639965)...

article

MP02-01 PROSTATE PHOTOVAPORIZATION VS. TRANSURETHRAL RESECTION OF THE PROSTATE: A MATCHED PAIRED ANALYSIS COMPARING THE BPH6 OUTCOME.

Sebastiano Cimino, Giorgio Ivan Russo, Salvatore Voce, Fabiano Palmieri, more

The Journal of Urology > 2017 > 197 > 4(S) > e9

article

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double‐blinded randomized study between single or combination therapy (PROCOMB trial)

Giuseppe Morgia, Giorgio I. Russo, Salvatore Voce, Fabiano Palmieri, more

The Prostate > 74 > 15 > 1471 - 1480

BACKGROUNDPhytotherapy has been used to treat patients with lower urinary tract symptoms (LUTS). We evaluated the efficacy and tolerability of combination therapy between Serenoa Repens (SeR), Lycopene (Ly), and Selenium (Se) + tamsulosin versus single therapies. METHODSPROCOMB trial (ISRCTN78639965) was a randomized double‐blinded, double‐dummy multicenter study of 225 patients between 55 and 80...

article

FIBROUS HAMARTOMA OF CORPUS CAVERNOSUM: A RARE CAUSE OF CONGENITAL PENILE CURVATURE ASSOCIATED WITH ERECTILE DYSFUNCTION

ALESSANDRO BERTACCINI, DEBORA MARCHIORI, CATIA GIOVANNINI, NUNZIO SALFI, more

The Journal of Urology > 2004 > 172 > 2 > 642-643

Filter options

Publication date

Set your own date range

Keywords

LUTS (3)
BPH (2)
LYCOPENE (2)
SELENIUM (2)
SERENOA REPENS (2)
ABNORMALITIES (1)
ANATOMICAL PHOTOSELECTIVE VAPORIZATION (1)
BENIGN PROSTATIC ENLARGEMENT (1)
GREENLIGHT LASER (1)
HAMARTOMA (1)
PENILE ERECTION (1)
PENILE NEOPLASMS (1)
PENIS (1)
PHYTOTHERAPY (1)
PREVENTION (1)
PROSTATE (1)
PROSTATE CANCER (1)
STANDARD PHOTOSELECTIVE VAPORIZATION (1)
TADALAFIL (1)
TAMSULOSIN (1)
more

Data set

Elsevier (3)
Wiley (2)
Springer (1)

INFONA - science communication portal

Search results for: Fabiano Palmieri

Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non‐inferiority, open‐label, clinical study (SPRITE study)

Standard vs. anatomical 180-W GreenLight laser photoselective vaporization of the prostate: a propensity score analysis

Association between selenium and lycopene supplementation and incidence of prostate cancer: Results from the post-hoc analysis of the procomb trial

MP02-01 PROSTATE PHOTOVAPORIZATION VS. TRANSURETHRAL RESECTION OF THE PROSTATE: A MATCHED PAIRED ANALYSIS COMPARING THE BPH6 OUTCOME.

Serenoa repens, lycopene and selenium versus tamsulosin for the treatment of LUTS/BPH. An Italian multicenter double‐blinded randomized study between single or combination therapy (PROCOMB trial)

FIBROUS HAMARTOMA OF CORPUS CAVERNOSUM: A RARE CAUSE OF CONGENITAL PENILE CURVATURE ASSOCIATED WITH ERECTILE DYSFUNCTION

Add recipient

Sending message cancelled

Are you sure you want to cancel sending this message?

Send message

Filter options

Publication date

Date range setting

Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.

Keywords

Data set

Journal

Reporting an error / abuse

Sending the report failed

Accessibility options